The global mammalian polyclonal IgG antibody market size is expected to reach USD 1.67 billion by 2030, registering a CAGR of 5.01% of the overall revenue. The industry has witnessed significant growth owing to the development of innovative drugs and increasing government initiatives. Pharma and biotech companies are indulging in rigorous research and development since the antibody-drug conjugate is considered to be the fastest-growing field of the pharmaceutical market. In October 2022, SAB Biotherapeutics announced an exclusive partnership with Emergent BioSolutions Inc. According to the agreement, Emergent BioSolutions is expected to offer end-to-end services of Contract Development and Manufacturing (CDMO) to produce polyclonal antibody-based products.
The partnership will enable SAB Biotherapeutics to primarily focus on the research and development of the polyclonal antibody drug pipeline. As of October 2022, the company is conducting various clinical-stage programs in the treatment of influenza, acute and recurrent C. diff., Type 1 diabetes and researching potential candidates in oncology and immunology. The COVID-19 pandemic surged the use of polyclonal antibodies across the globe. For instance, in July 2022, GigaGen Inc. announced the publication of research showcasing its studies of GIGA-2050, recombinant polyclonal antibodies for COVID-19. According to the research, the GIGA-2050 has an effective manufacturing approach to treating infectious diseases by targeting numerous viral epitopes.
The company has leveraged its existing technology to develop medicines for infectious diseases. Key companies are continuously expanding their product and service portfolios to accelerate the development and manufacturing of the product. For instance, in October 2022, Amerigo Scientific, a distributor, introduced its recent development of polyclonal antibodies to human blood coagulation factor XIII to assist professionals in the area of life science for detecting blood coagulation factor XIII. However, the product is solely for research purposes and not for therapeutic or diagnostics. The development of this product is expected to strengthen the company’s position in biomedical research applications.
Mammalian Polyclonal IgG Antibody Market Report Highlights
- Based on types, the mouse segment is expected to register the fastest CAGR during the forecast period. The growth is attributed to the similar characteristic of its immune system as humans, resulting in low variation of the outcome during the trials
- Based on products, the metabolic biomarkers segment captured the largest share in 2022 due to the high incidence of chronic diseases
- The ELISA application segment is estimated to hold the largest share by 2030. As it offers more accurate diagnoses of diseases, such as AIDS, Lyme disease, Rocky Mountain spotted fever, chickenpox, squamous cell carcinoma, syphilis, shingles, and other infections, than other antibody-based assays.
- The pharma & biotech companies end-user segment held the highest share in 2022and is likely to remain dominant over the forecast period
- Companies are focusing on the adoption of smarter, novel, and advanced approaches for the development of new diagnostic tests & drugs
- North America dominated the industry in 2022 due to the presence of prominent players, advanced healthcare infrastructure, and high healthcare expenditure
- Asia Pacific is expected to register the fastest CAGR over the forecast period due to untapped opportunities, rising healthcare expenditure, and the growing regional presence of major global players
Table of Contents
Chapter 1 Methodology and Scope1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecasts Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Sample Size For The Study On Personalized Nutrition & Supplements Market
1.3.5.1 Primary Sources
1.3.5.2 Details Of Primary Research
1.3.5.3 Secondary Data Sources
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Market Model
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Trends And Outlook
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related Market Outlook
3.3 Penetration & Growth Prospect Mapping, 2022
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Advantages Over Monoclonal Antibodies
3.4.1.2 Rising R&D Investments
3.4.1.3 Increasing Adoption Of Novel Diagnostic Procedures
3.4.2 Market Restraint Analysis
3.4.2.1 Stringent Regulatory Policies
3.5 Business Environment Analysis
3.5.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.5.2 Porter’s Five Forces Analysis
3.6 Covid-19 Impact Analysis
Chapter 4 Type Business Analysis
4.1 Mammalian Polyclonal Igg Antibody Market: Type Movement Analysis
4.2 Goat
4.2.1 Goat Market Estimates And Forecast For 2018 - 2030 (USD Million)
4.3 Rabbit
4.3.1 Rabbit Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Horse
4.4.1 Horse Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5 Mouse
4.5.1 Mouse Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Others Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Product Business Analysis
5.1 Mammalian Polyclonal Igg Antibody Market: Product Movement Analysis
5.2 Cardiac Biomarkers
5.2.1 Cardiac Biomarkers Market Estimates And Forecast For 2018 - 2030 (USD Million)
5.3 Metabolic Biomarkers
5.3.1 Metabolic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Renal Biomarkers
5.4.1 Renal Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Other
5.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Mammalian Polyclonal Igg Antibody Market: Application Movement Analysis
6.2 Elisa
6.2.1 Elisa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Immunoturbidimetry
6.3.1 Immunoturbidimetry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Immunoelectrophoresis
6.4.1 Immunoelectrophoresis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Antibody Identification
6.5.1 Antibody Identification Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Immunohistochemistry
6.6.1 Immunohistochemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.7 Immunocytochemistry
6.7.1 Immunocytochemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Western Blotting
6.6.1 Western Blotting Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 End-Users Business Analysis
7.1 Mammalian Polyclonal Igg Antibody Market: End-Users Movement Analysis
7.2 Pharmaceutical And Biotechnology Companies
7.2.2 Pharmaceutical And Biotechnology Companies Market Estimates And Forecast For 2018 - 2030 (USD Million)
7.3 Hospitals
7.3.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Diagnostic Centers
7.4.1 Diagnostic Centers Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Academic And Research Centers
7.5.1 Academic And Research Centers Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Mammalian polyclonal IgG antibody market share by region, 2022 & 2030
8.2 Global Outlook
8.3 North America
8.3.1 SWOT Analysis
8.3.1.1 North America mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.3.1.2 North America mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.3.1.3 North America mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.3.1.4 North America mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Regulatory Framework
8.3.2.4 Reimbursement Scenario
8.3.2.5 U.S. mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.3.2.6 U.S. mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.3.2.7 U.S. mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.3.2.8 U.S. mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Regulatory Framework
8.3.3.4 Reimbursement Scenario
8.3.3.5 Canada mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.3.3.6 Canada mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.3.3.7 Canada mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.3.3.8 Canada mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4 Europe
8.4.1 SWOT Analysis
8.4.1.1 Europe mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.1.2 Europe mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.1.3 Europe mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.1.4 Europe mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.2 Germany
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 Reimbursement Scenario
8.4.2.5 Germany mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.2.6 Germany mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.2.7 Germany mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.2.8 Germany mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.3 U.K.
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Reimbursement Scenario
8.4.3.5 U.K. mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.3.6 U.K. mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.3.7 U.K. mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.3.8 U.K. mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.4 France
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 Reimbursement Scenario
8.4.4.5 France mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.4.6 France mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.4.7 France mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.4.8 France mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Reimbursement Scenario
8.4.5.5 Italy mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.5.6 Italy mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.5.7 Italy mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.5.8 Italy mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Reimbursement Scenario
8.4.6.5 Spain mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.6.6 Spain mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.6.7 Spain mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.6.8 Spain mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.7 Denmark
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Regulatory Framework
8.4.7.4 Reimbursement Scenario
8.4.7.5 Denmark mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.7.6 Denmark mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.7.7 Denmark mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.7.8 Denmark mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.8 Sweden
8.4.8.1 Key Country Dynamics
8.4.8.2 Competitive Scenario
8.4.8.3 Regulatory Framework
8.4.8.4 Reimbursement Scenario
8.4.8.5 Sweden mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.8.6 Sweden mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.8.7 Sweden mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.8.8 Sweden mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.4.9 Norway
8.4.9.1 Key Country Dynamics
8.4.9.2 Competitive Scenario
8.4.9.3 Regulatory Framework
8.4.9.4 Reimbursement Scenario
8.4.9.5 Norway mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.4.9.6 Norway mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.4.9.7 Norway mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.4.9.8 Norway mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5 Asia Pacific
8.5.1 SWOT Analysis
8.5.1.1 Asia Pacific mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.1.2 Asia Pacific mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.1.3 Asia Pacific mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.1.4 Asia Pacific mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 Reimbursement Scenario
8.5.2.5 Japan mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.2.6 Japan mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.2.7 Japan mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.2.8 Japan mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5.3 China
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Reimbursement Scenario
8.5.3.5 China mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.3.6 China mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.3.7 China mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.3.8 China mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5.4 India
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Reimbursement Scenario
8.5.4.5 India mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.4.6 India mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.4.7 India mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.4.8 India mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5.5 South Korea
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Reimbursement Scenario
8.5.5.5 South Korea mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.5.6 South Korea mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.5.7 South Korea mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.5.8 South Korea mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5.6 Australia
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 Reimbursement Scenario
8.5.6.5 Australia mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.6.6 Australia mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.6.7 Australia mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.6.8 Australia mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.5.7 Thailand
8.5.7.1 Key Country Dynamics
8.5.7.2 Competitive Scenario
8.5.7.3 Regulatory Framework
8.5.7.4 Reimbursement Scenario
8.5.7.5 Thailand mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.5.7.6 Thailand mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.5.7.7 Thailand mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.5.7.8 Thailand mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.6 Latin America
8.6.1 SWOT Analysis
8.6.1.1 Latin America mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.6.1.2 Latin America mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.6.1.3 Latin America mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.6.1.4 Latin America mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Regulatory Framework
8.6.2.4 Reimbursement Scenario
8.6.2.5 Brazil mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.6.2.6 Brazil mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.6.2.7 Brazil mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.6.2.8 Brazil mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Regulatory Framework
8.6.3.4 Reimbursement Scenario
8.6.3.5 Mexico mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.6.3.6 Mexico mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.6.3.7 Mexico mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.6.3.8 Mexico mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.6.4 Argentina
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Regulatory Framework
8.6.4.4 Reimbursement Scenario
8.6.4.5 Argentina mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.6.4.6 Argentina mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.6.4.7 Argentina mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.6.4.8 Argentina mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.7 MEA
8.7.1 SWOT Analysis
8.7.1.1 MEA mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.7.1.2 MEA mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.7.1.3 MEA mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.7.1.4 MEA mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 Competitive Scenario
8.7.2.2 Regulatory Framework
8.7.2.3 Reimbursement Scenario
8.7.2.4 Argentina mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.7.2.5 Argentina mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.7.2.6 Argentina mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.7.2.7 Argentina mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Key Country Dynamics
8.7.3.2 Competitive Scenario
8.7.3.3 Regulatory Framework
8.7.3.4 Reimbursement Scenario
8.7.3.5 Saudi Arabia mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.7.3.6 Saudi Arabia mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.7.3.7 Saudi Arabia mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.7.3.8 Saudi Arabia mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.7.4 UAE
8.7.4.1 Key Country Dynamics
8.7.4.2 Competitive Scenario
8.7.4.3 Regulatory Framework
8.7.4.4 Reimbursement Scenario
8.7.4.5 UAE mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.7.4.6 UAE mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.7.4.7 UAE mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.7.4.8 UAE mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
8.7.5 Kuwait
8.7.5.1 Key Country Dynamics
8.7.5.2 Competitive Scenario
8.7.5.3 Regulatory Framework
8.7.5.4 Reimbursement Scenario
8.7.5.5 Kuwait mammalian polyclonal IgG antibody market, by type, 2018 - 2030 (USD Million)
8.7.5.6 Kuwait mammalian polyclonal IgG antibody market, by product, 2018 - 2030 (USD Million)
8.7.5.7 Kuwait mammalian polyclonal IgG antibody market, by application, 2018 - 2030 (USD Million)
8.7.5.8 Kuwait mammalian polyclonal IgG antibody market, by end-user, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Participant’s overview
9.1.1 Abcam plc.
9.1.2 Bio-Rad Laboratories
9.1.3 Thermo Fisher Scientific
9.1.4 Novartis AG
9.1.5 Geno Technology Inc.
9.1.6 Merck KGaA
9.1.7 Cell Signaling Technologies
9.1.8 F. Hoffmann-La Roche Ltd
9.1.9 Stemcell Technologies Inc.
9.1.10 Phoenix Pharmaceuticals
9.2 Financial performance
9.3 Participant categorization
9.3.1 Market leaders
9.3.1.1 Mammalian polyclonal IgG antibody market share analysis, 2022
9.3.2 Strategy mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/service launch
9.3.2.5 Partnerships
9.3.2.6 Others
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 4 Global Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 6 Global Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 7 Global Mammalian polyclonal IgG antibody market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Mammalian polyclonal IgG antibody market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 10 North America Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 11 North America Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 12 North America Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 13 U.S. Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 14 U.S. Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 15 U.S. Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 16 U.S. Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 17 Canada Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 18 Canada Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 19 Canada Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 20 Canada Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 21 Europe Mammalian polyclonal IgG antibody market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 23 Europe Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 24 Europe Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 25 Europe Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 26 Germany Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 27 Germany Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 28 Germany Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 29 Germany Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 30 U.K. Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 31 U.K. Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 32 U.K. Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 33 U.K. Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 34 France Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 35 France Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 36 France Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 37 France Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 38 Italy Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 39 Italy Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 40 Italy Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 41 Italy Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 42 Spain Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 43 Spain Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 44 Spain Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 45 Spain Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 46 Denmark Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 47 Denmark Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 48 Denmark Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 49 Denmark Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 50 Sweden Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 51 Sweden Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 52 Sweden Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 53 Sweden Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 54 Norway Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 55 Norway Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 56 Norway Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 57 Norway Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Mammalian polyclonal IgG antibody market, by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 63 China Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 64 China Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 65 China Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 66 China Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 67 Japan Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 68 Japan Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 69 Japan Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 70 Japan Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 71 India Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 72 India Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 73 India Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 74 India Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 75 South Korea Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 76 South Korea Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 77 South Korea Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 78 South Korea Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 79 Australia Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 80 Australia Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 81 Australia Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 82 Australia Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 83 Thailand Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 84 Thailand Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 85 Thailand Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 86 Thailand Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 87 Latin America Mammalian polyclonal IgG antibody market, by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 89 Latin America Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 90 Latin America Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 91 Latin America Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 92 Brazil Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 93 Brazil Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 94 Brazil Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 95 Brazil Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 96 Mexico Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 97 Mexico Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 98 Mexico Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 99 Mexico Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 100 Argentina Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 101 Argentina Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 102 Argentina Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 103 Argentina Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 109 South Africa Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 110 South Africa Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 111 South Africa Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 112 South Africa Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 117 UAE Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 118 UAE Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 119 UAE Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
Table 120 UAE Mammalian polyclonal IgG antibody market, by Type, 2018 - 2030 (USD Million)
Table 121 Kuwait Mammalian polyclonal IgG antibody market, by Product, 2018 - 2030 (USD Million)
Table 122 Kuwait Mammalian polyclonal IgG antibody market, by Application, 2018 - 2030 (USD Million)
Table 123 Kuwait Mammalian polyclonal IgG antibody market, by End-user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Mammalian IgG Polyclonal Antibody Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Mammalian polyclonal IgG antibody market: Type Movement Analysis
Fig. 17 Global Mammalian polyclonal IgG antibody market, for Goat, 2018 - 2030 (USD Million)
Fig. 18 Global Mammalian polyclonal IgG antibody market, for Rabbit, 2018 - 2030 (USD Million)
Fig. 19 Global Mammalian polyclonal IgG antibody market, for Horse, 2018 - 2030 (USD Million)
Fig. 20 Global Mammalian polyclonal IgG antibody market, for Mouse, 2018 - 2030 (USD Million)
Fig. 21 Global Mammalian polyclonal IgG antibody market, for Others, 2018 - 2030 (USD Million)
Fig. 22 Global Mammalian polyclonal IgG antibody market: Product Movement Analysis
Fig. 23 Global Mammalian polyclonal IgG antibody market, for Cardiac biomarkers, 2018 - 2030 (USD Million)
Fig. 24 Global Mammalian polyclonal IgG antibody market, for Metabolic biomarkers, 2018 - 2030 (USD Million)
Fig. 25 Global Mammalian polyclonal IgG antibody market, for Renal Biomarkers, 2018 - 2030 (USD Million)
Fig. 26 Global Mammalian polyclonal IgG antibody market, for Others, 2018 - 2030 (USD Million)
Fig. 27 Global Mammalian polyclonal IgG antibody market: Application Movement Analysis
Fig. 28 Global Mammalian polyclonal IgG antibody market, for ELISA, 2018 - 2030 (USD Million)
Fig. 29 Global Mammalian polyclonal IgG antibody market, for Immunoturbidimetry, 2018 - 2030 (USD Million)
Fig. 30 Global Mammalian polyclonal IgG antibody market, for Immunoelectrophoresis, 2018 - 2030 (USD Million)
Fig. 31 Global Mammalian polyclonal IgG antibody market, for Antibody identification, 2018 - 2030 (USD Million)
Fig. 32 Global Mammalian polyclonal IgG antibody market, for Immunohistochemistry, 2018 - 2030 (USD Million)
Fig. 33 Global Mammalian polyclonal IgG antibody market, for Immunocytochemistry, 2018 - 2030 (USD Million)
Fig. 34 Global Mammalian polyclonal IgG antibody market, for Western blotting, 2018 - 2030 (USD Million)
Fig. 35 Global Mammalian polyclonal IgG antibody market: End-user Movement Analysis
Fig. 36 Global Mammalian polyclonal IgG antibody market, for Pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
Fig. 37 Global Mammalian polyclonal IgG antibody market, for Hospitals, 2018 - 2030 (USD Million)
Fig. 38 Global Mammalian polyclonal IgG antibody market, for Diagnostic centers, 2018 - 2030 (USD Million)
Fig. 39 Global Mammalian polyclonal IgG antibody market, for Academic and Research Centers, 2018 - 2030 (USD Million)
Fig. 40 Regional Marketplace: Key Takeaways
Fig. 41 Regional Outlook, 2022 & 2030
Fig. 42 Global Mammalian polyclonal IgG antibody market: Region Movement Analysis
Fig. 43 North America Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 44 U.S. Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 45 Canada Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 46 Europe Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 47 Germany Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 48 U.K. Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 49 France Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 50 Italy Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 51 Spain Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 52 Denmark Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 53 Sweden Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 54 Norway Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 56 Japan Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 57 China Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 58 India Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 59 Australia Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 60 South Korea Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 61 Thailand Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 62 Latin America Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 63 Brazil Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 64 Mexico Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 65 Argentina Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 66 Middle East and Africa Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 67 South Africa Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 68 Saudi Arabia Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 69 UAE Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Fig. 70 Kuwait Mammalian polyclonal IgG antibody market, 2018 - 2030 (USD Million)
Companies Mentioned
- Abcam plc.
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Novartis AG
- Geno Technology Inc.
- Merck KGaA
- Cell Signaling Technologies
- F. Hoffmann-La Roche Ltd
- Stemcell Technologies Inc.
- Phoenix Pharmaceuticals
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | February 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.13 Billion |
| Forecasted Market Value ( USD | $ 1.67 Billion |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
